[Radiotherapy as therapeutic option for primary localised orbital lymphomas of low malignancy].
OBJECTIVE
The aim of this study was to assess the efficacy of radiotherapy as first line therapy for the treatment of primary localised orbital lymphomas of low malignancy (St IE) based on our cases.


METHODS
7 patients with histologically proven primary localised orbital lymphomas of low malignancy treated with radiotherapy were retrospectively reviewed. The dose was 40 Gy for unilateral and 36 Gy for bilateral lymphoma. The follow-up period was 12 - 60 months after the end of the therapy (mean follow-up period: 36 months).


RESULTS
Complete regression was achieved in 6 patients 12 - 24 months after the end of radiotherapy. In one patient an increase of tumour mass was observed 3 months after radiotherapy. Chemotherapy was subsequently performed and the patient was free of disease 2 years later. In 2 cases cataract surgery had to be performed for post-radiotherapy cataract formation.


CONCLUSIONS
The majority of orbital lymphomas are localised St. IE tumours of low malignancy. Radiotherapy is the first-line therapy in these cases. Success rates of > 90 % are reported in the literature.
Manousaridis
K
K
Klinik und Poliklinik für Augenheilkunde, Universität Rostock. klemanousaridis@kabelmail.de
Beck
R
R
Klautke
G
G
Hingst
V
V
Guthoff
R
R
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009918:Orbital Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy*; D016896:Treatment Outcome